共 48 条
- [1] Benedict RH(2006)Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis Arch Neurol 63 1301-1306
- [2] Zivadinov R(2016)A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients Mult Scler J 22 1709-1718
- [3] Sormani MP(2014)Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis Ann Neurol 75 43-49
- [4] Arnold DL(2018)Progression of regional grey matter atrophy in multiple sclerosis Brain 141 1665-1677
- [5] De Stefano N(2021)Effects of ibudilast on MRI measures in the phase 2 SPRINT-MS study Neurology 96 e491-e500
- [6] Eshaghi A(2017)Brain atrophy in multiple sclerosis: clinical relevance and technical aspects Neuroimaging Clin 27 289-300
- [7] Naismith RT(2021)2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis Lancet Neurol 20 653-670
- [8] Sastre-Garriga J(2017)Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosis NeuroImage Clin 15 769-779
- [9] Pareto D(2021)DeepGRAI (Deep Gray Rating via Artificial Intelligence): fast, feasible, and clinically relevant thalamic atrophy measurement on clinical quality T2-FLAIR MRI in multiple sclerosis NeuroImage Clin 30 102652-842
- [10] Rovira À(2021)FLAIR-only joint volumetric analysis of brain lesions and atrophy in clinically isolated syndrome (CIS) suggestive of multiple sclerosis NeuroImage Clin 29 102542-783